# Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Source: https://onco.cc/trials/nct02843945/  
OnCo record `nct02843945` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of Directional Brachytherapy Source Implant in pancreatic ductal adenocarcinoma, run by CivaTech Oncology, now recruiting.

## Summary

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source is a phase 1/2 interventional study registered as NCT02843945 by CivaTech Oncology, with 80 participants planned, started 2017-05-31 and due to reach its primary completion in 2027-10-29. Interventions recorded: Directional Brachytherapy Source Implant.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT02843945
- Phase: 1/2
- Setting: Initial Feasibility Study to Evaluate the Safety and Efficacy of the Permanently Implantable LDR CivaSheet® in Combination With External Beam Radiation in the Treatment of Pancreatic Cancer
- Sponsor: CivaTech Oncology
- Enrolled: 80

## Sources

- ClinicalTrials.gov NCT02843945: https://clinicaltrials.gov/study/NCT02843945

## Connected records

- cancers: [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- companies: [CivaTech Oncology](https://onco.cc/companies/civatech-oncology/)

---
JSON: https://onco.cc/api/v1/entities/nct02843945.json